tiprankstipranks
Trending News
More News >
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
US Market
Advertisement

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

Compare
1,678 Followers
See the Price Targets and Ratings of:

GEHC Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
5 Buy
4 Hold
0 Sell
Based on 9 analysts giving stock ratings to
GE
Healthcare Technologies Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GEHC Stock 12 Month Forecast

Average Price Target

$86.33
▲(11.57% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is $86.33 with a high forecast of $92.00 and a low forecast of $80.00. The average price target represents a 11.57% change from the last price of $77.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"$66","93":"$93","72.75":"$72.8","79.5":"$79.5","86.25":"$86.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$92.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$86.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,72.75,79.5,86.25,93],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.48,76.75076923076924,78.02153846153847,79.2923076923077,80.56307692307692,81.83384615384615,83.10461538461539,84.37538461538462,85.64615384615385,86.91692307692308,88.18769230769232,89.45846153846153,90.72923076923077,{"y":92,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.48,76.3146153846154,77.14923076923077,77.98384615384616,78.81846153846153,79.65307692307692,80.48769230769231,81.32230769230769,82.15692307692308,82.99153846153847,83.82615384615384,84.66076923076923,85.49538461538461,{"y":86.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.48,75.82769230769232,76.17538461538462,76.52307692307693,76.87076923076923,77.21846153846154,77.56615384615385,77.91384615384615,78.26153846153846,78.60923076923078,78.95692307692308,79.30461538461539,79.65230769230769,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":91.47,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.79,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.93,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.04,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.22,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.61,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.88,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.82,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.57,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.48,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$92.00Average Price Target$86.33Lowest Price Target$80.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on GEHC
Wells Fargo
Wells Fargo
$89$87
Buy
12.43%
Upside
Reiterated
10/30/25
GE Healthcare Technologies Inc (GEHC) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on GEHC
Morgan Stanley
Morgan Stanley
$74$80
Hold
3.39%
Upside
Reiterated
10/30/25
Balanced Outlook on GE Healthcare Technologies Inc: Hold Recommendation Amid Market UncertaintiesWe value GEHC on EV/EBITDA using 2027 estimates (the point where margins hit steady state) and discount back to today at the cost of equity (10%). We use a 16.1x target multiple, based on rough valuation parity to market leader SHL.
TR | OpenAI - 4o Analyst forecast on GEHC
TR | OpenAI - 4o
TR | OpenAI - 4o
$83$90
Buy
16.31%
Upside
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
Mizuho Securities Analyst forecast on GEHC
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$95
Buy
22.77%
Upside
Reiterated
10/30/25
Bank of America Securities Analyst forecast on GEHC
Bank of America Securities
Bank of America Securities
$82
Hold
5.97%
Upside
Reiterated
10/29/25
GE Healthcare Technologies Inc.: Strong Q3 Performance Overshadowed by Conservative Guidance and Cautious Product Launch
BTIG
$89$87
Buy
12.43%
Upside
Reiterated
10/29/25
GE HealthCare price target lowered to $87 from $89 at BTIGGE HealthCare price target lowered to $87 from $89 at BTIG
Barclays Analyst forecast on GEHC
Barclays
Barclays
$86
Hold
11.14%
Upside
Initiated
10/13/25
GE HealthCare initiated with an Equal Weight at BarclaysGE HealthCare initiated with an Equal Weight at Barclays
Citi
$93$83
Hold
7.26%
Upside
Downgraded
10/07/25
GE HealthCare downgraded to Neutral from Buy at CitiGE HealthCare downgraded to Neutral from Buy at Citi
Evercore ISI Analyst forecast on GEHC
Evercore ISI
Evercore ISI
$88
Buy
13.72%
Upside
Reiterated
10/07/25
Evercore ISI Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
Exane BNP Paribas Analyst forecast on GEHC
Exane BNP Paribas
Exane BNP Paribas
$92
Buy
18.89%
Upside
Reiterated
09/10/25
GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP ParibasBNP Paribas Exane analyst Navann Ty reiterated an Outperform rating and $92.00 price target on GE HealthCare (NASDAQ: GEHC).
Stifel Nicolaus Analyst forecast on GEHC
Stifel Nicolaus
Stifel Nicolaus
$90
Buy
16.31%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Axsome Therapeutics (NASDAQ: AXSM) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Oppenheimer Analyst forecast on GEHC
Oppenheimer
Oppenheimer
$89
Buy
15.02%
Upside
Reiterated
07/31/25
Oppenheimer Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Goldman Sachs Analyst forecast on GEHC
Goldman Sachs
Goldman Sachs
$82$85
Buy
9.85%
Upside
Reiterated
06/10/25
Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization
UBS
$73
Hold
-5.66%
Downside
Upgraded
05/05/25
GE HealthCare upgraded to Neutral from Sell at UBSGE HealthCare upgraded to Neutral from Sell at UBS
Jefferies
$110$95
Buy
22.77%
Upside
Reiterated
04/30/25
Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on GEHC
Wells Fargo
Wells Fargo
$89$87
Buy
12.43%
Upside
Reiterated
10/30/25
GE Healthcare Technologies Inc (GEHC) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on GEHC
Morgan Stanley
Morgan Stanley
$74$80
Hold
3.39%
Upside
Reiterated
10/30/25
Balanced Outlook on GE Healthcare Technologies Inc: Hold Recommendation Amid Market UncertaintiesWe value GEHC on EV/EBITDA using 2027 estimates (the point where margins hit steady state) and discount back to today at the cost of equity (10%). We use a 16.1x target multiple, based on rough valuation parity to market leader SHL.
TR | OpenAI - 4o Analyst forecast on GEHC
TR | OpenAI - 4o
TR | OpenAI - 4o
$83$90
Buy
16.31%
Upside
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
Mizuho Securities Analyst forecast on GEHC
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$95
Buy
22.77%
Upside
Reiterated
10/30/25
Bank of America Securities Analyst forecast on GEHC
Bank of America Securities
Bank of America Securities
$82
Hold
5.97%
Upside
Reiterated
10/29/25
GE Healthcare Technologies Inc.: Strong Q3 Performance Overshadowed by Conservative Guidance and Cautious Product Launch
BTIG
$89$87
Buy
12.43%
Upside
Reiterated
10/29/25
GE HealthCare price target lowered to $87 from $89 at BTIGGE HealthCare price target lowered to $87 from $89 at BTIG
Barclays Analyst forecast on GEHC
Barclays
Barclays
$86
Hold
11.14%
Upside
Initiated
10/13/25
GE HealthCare initiated with an Equal Weight at BarclaysGE HealthCare initiated with an Equal Weight at Barclays
Citi
$93$83
Hold
7.26%
Upside
Downgraded
10/07/25
GE HealthCare downgraded to Neutral from Buy at CitiGE HealthCare downgraded to Neutral from Buy at Citi
Evercore ISI Analyst forecast on GEHC
Evercore ISI
Evercore ISI
$88
Buy
13.72%
Upside
Reiterated
10/07/25
Evercore ISI Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
Exane BNP Paribas Analyst forecast on GEHC
Exane BNP Paribas
Exane BNP Paribas
$92
Buy
18.89%
Upside
Reiterated
09/10/25
GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP ParibasBNP Paribas Exane analyst Navann Ty reiterated an Outperform rating and $92.00 price target on GE HealthCare (NASDAQ: GEHC).
Stifel Nicolaus Analyst forecast on GEHC
Stifel Nicolaus
Stifel Nicolaus
$90
Buy
16.31%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Axsome Therapeutics (NASDAQ: AXSM) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Oppenheimer Analyst forecast on GEHC
Oppenheimer
Oppenheimer
$89
Buy
15.02%
Upside
Reiterated
07/31/25
Oppenheimer Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Goldman Sachs Analyst forecast on GEHC
Goldman Sachs
Goldman Sachs
$82$85
Buy
9.85%
Upside
Reiterated
06/10/25
Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization
UBS
$73
Hold
-5.66%
Downside
Upgraded
05/05/25
GE HealthCare upgraded to Neutral from Sell at UBSGE HealthCare upgraded to Neutral from Sell at UBS
Jefferies
$110$95
Buy
22.77%
Upside
Reiterated
04/30/25
Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

1 Month
xxx
Success Rate
11/18 ratings generated profit
61%
Average Return
+1.12%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +1.12% per trade.
3 Months
xxx
Success Rate
7/9 ratings generated profit
78%
Average Return
-0.39%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of -0.39% per trade.
1 Year
Isla CarelynxTR | OpenAI - 4o
Success Rate
4/8 ratings generated profit
50%
Average Return
-0.27%
reiterated a buy rating 13 days ago
Copying Isla Carelynx's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.27% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
-0.27%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GEHC Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
2
0
0
0
0
Buy
21
22
24
20
14
Hold
10
6
2
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
28
26
24
19
In the current month, GEHC has received 14 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. GEHC average Analyst price target in the past 3 months is 86.33.
Each month's total comprises the sum of three months' worth of ratings.

GEHC Financial Forecast

GEHC Earnings Forecast

Next quarter’s earnings estimate for GEHC is $1.41 with a range of $1.33 to $1.45. The previous quarter’s EPS was $1.07. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year GEHC has Preformed in-line its overall industry.
Next quarter’s earnings estimate for GEHC is $1.41 with a range of $1.33 to $1.45. The previous quarter’s EPS was $1.07. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year GEHC has Preformed in-line its overall industry.

GEHC Sales Forecast

Next quarter’s sales forecast for GEHC is $5.61B with a range of $5.48B to $5.70B. The previous quarter’s sales results were $5.14B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year GEHC has Preformed in-line its overall industry.
Next quarter’s sales forecast for GEHC is $5.61B with a range of $5.48B to $5.70B. The previous quarter’s sales results were $5.14B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year GEHC has Preformed in-line its overall industry.

GEHC Stock Forecast FAQ

What is GEHC’s average 12-month price target, according to analysts?
Based on analyst ratings, GE Healthcare Technologies Inc’s 12-month average price target is 86.33.
    What is GEHC’s upside potential, based on the analysts’ average price target?
    GE Healthcare Technologies Inc has 11.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GEHC a Buy, Sell or Hold?
          GE Healthcare Technologies Inc has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 0 sell ratings.
            What is GE Healthcare Technologies Inc’s price target?
            The average price target for GE Healthcare Technologies Inc is 86.33. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $92.00 ,the lowest forecast is $80.00. The average price target represents 11.57% Increase from the current price of $77.38.
              What do analysts say about GE Healthcare Technologies Inc?
              GE Healthcare Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of GEHC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis